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Objectives
The aim of this study is to analyze the effect of preventive
measures for development of contrast associated acute
kidney injury (CA-AKI), controlling the maximum num-
ber of factors confounders using propensity score
methodology.
Methods
We performed a prospective multi-center study, in 34
Spanish ICU, covering the period from 15 December 2012
to 15 March 2013. During this study period, we included
1035 patients, all of them undergoing a radiographic
examination or a coronary angiography with administra-
tion of parenteral iodinated contrast media. We excluded
patients with incomplete data or renal replacement ther-
apy at the time of the study, being finally 1012 patientes.
We defined CA-AKI as an increase of serum creatinine ≥,
0,5 mg/dl, or ≥ 50 % from baseline, assessed 48-72 hours
after the procedure. We calculate a propensity score
through regression and subsequent pairing 1:1 by quintiles
clustering. The final analysis was performed using logistic
regression, including the propensity score and factors that
could not be balanced.
Results
Preventive measures were applied in 29,4% of patients:
53,8 % surgical patients, 30,1% medical patients, and
18,6 % coronary patients, p < 0,001. The most common
choice was volume loading (22,6%), especially in younger
patients (60.02-0.94 vs 63.02-0.55, p < 0.05), more severely
ill patients (APACHE 14,3-0,45 vs 11.9-0.28, p < 0.001),
and patients with worse baseline creatinine (1.08-0.35 vs
0.94-0.01, p < 0.001) and at time of contrast administra-
tion (1.24-0.46 vs 1.01-0.02, p < 0.001). Also we applied
more preventive measures in patients with chronic kidney
disease stage ≥ 2. The incidence of CA-AKI was higher in
patients who received preventive measures, OR 1.73, (95%
CI 1.17-2.56) and an absolute difference of 6,2%
(IC 1,2-11,2). We estimate a propensity score considering:
type of hospital and patient, age, chronic kidney disease,
baseline serum creatinine, APACHE II, serum creatinine
at time of contrast administration, volume of contrast, glu-
cose and hemoglobin at time of contrast administration,
vasoactive therapy, NSAID, ACEI and shock. In the final
regression analysis, we included the type of patient,
volume of contrast, use of ACEIS and glucose and hemo-
globin levels. After pairing, OR for preventive measures
was 1,19 (0,71-2,14), and finally, after controlling for other
variables mentioned, we obtained an increase in the risk of
CA-AKI in patients with prophylaxis of 1,1 (0,7-1,72), no
significant.
Conclusions
CA-AKI is apparently more frequent after the application
of preventive measures, this is due to the numerous vari-
ables which interfere in the decision on your application.
However, in our cohort we have failed to either show a
definitive positive effect on its appearance.
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